agilon health, inc. (AGL) company profile
Close on Nov 17, 2026Market cap $1.93BP/E –Yield –
About agilon health
Services-Misc Health & Allied Services, NEC, SIC 8090
agilon health operates a healthcare platform that collaborates with community-based primary care physicians to establish globally capitated, Medicare-centric care models. Through long-term partnership agreements, the company provides infrastructure, operational processes, capital, and technology—including its CORE system, HCC Manager software, and Minerva clinical data platform—to enable independent physician practices to transition to value-based care. Under this Total Care Model, the organization forms risk-bearing entities that contract with health plan payors to manage the comprehensive healthcare needs and associated medical expenses of attributed Medicare patients.
The business operates across 30 geographic areas within the United States, including Connecticut, Georgia, Illinois, Kentucky, Michigan, Minnesota, New York, North Carolina, Ohio, Pennsylvania, Tennessee, and Texas. Its network encompasses 28 anchor physician groups serving roughly 511,000 Medicare Advantage members alongside 114,000 Medicare fee-for-service beneficiaries through nine accountable care organizations. The company directly employs 856 people, but the provided text does not state its headquarters location.
Summary of the business section of agilon health's latest annual report, written by StockData.
Company profile
Company
- Legal name
- agilon health, inc.
- Founded
- 2016
- Headquarters
- Westerville, OH
- Address
- 440 Polaris Parkway, Suite 550 43082
- Phone
- (562) 256-3800
- Website
- agilonhealth.com
- Employees
- 856, Dec 31, 2025
- Industry
- Services-Misc Health & Allied Services, NEC
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Ernst & Young LLP, Los Angeles, California
Stock & identifiers
- Ticker
- AGL
- Exchange
- NYSE
- IPO date
- Apr 16, 2021
- Shares outstanding
- 17M, Jul 30, 2026
- Public float
- $709.40M, Jun 30, 2025
- Filer category
- Large accelerated filer
- Stock splits
- 1-for-25 reverse, Mar 31, 2026
- SEC CIK
- 1831097
- CUSIP
- 00857U206
- ISIN
- US00857U2069
- FIGI
- BBG00HCYVQQ4
- Share class FIGI
- BBG00HCYVQR3
- EIN
- 37-1915147
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Timothy Patrick O'Rourke | CEO & President, Director | 120,000 |
| Steven Sell | CEO & President, Director | 943,910 |
| Timothy Gertsch | Chief Accounting Officer | 14,152 |
| Denise Zamore | Chief Legal Officer | 66,075 |
| Jeffrey A. Schwaneke | Chief Financial Officer | 138,923 |
| Girish Venkatachaliah | Chief Technology Officer | 38,236 |
| Benjamin Shaker | Chief Markets Officer | 122,850 |
| Sharad Mansukani | Director | 56,242 |
| Silvana Battaglia | Director | 7,926 |
| Diana McKenzie | Director | 7,633 |
| Ronald A. Williams | Director | 149,141 |
| Karen McLoughlin | Director | 8,207 |
| John William Wulf | Director | 16,765 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Benjamin Shaker | $5.36M | $1.38M | $2.59M | $3 | $142 |
| FY2025 Jeffrey Schwaneke | $5.61M | $1.13M | $2.59M | $3 | $142 |
| FY2025 Steven Sell | $7.28M | $715.64K | $2.59M | $3 | $142 |
| FY2024 | $5.42M | -$10.64M | $3.72M | $8 | $124 |
| FY2023 | $5.27M | -$3.57M | $2.74M | $55 | $120 |
| FY2022 | $5.79M | -$30.81M | $1.96M | $70 | $118 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Stock awards | Option awards | Incentive pay | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|---|
| Jeffrey Schwaneke Chief Financial Officer and Interim Co-Principal Executive Officer | $625.00K | $2.95M | $1.75M | $271.88K | $14.00K | $5.61M | -21% |
| Benjamin Shaker Chief Markets Officer and Interim Co-Principal Executive Officer | $450.00K | $2.95M | $1.75M | $193.55K | $14.00K | $5.36M | +31% |
| Girish Venkatachaliah Chief Technology Officer | $425.00K | $937.51K | $500.00K | $184.88K | $8.70K | $2.06M | -20% |
| Denise Zamore Chief Legal Officer and Corporate Secretary | $425.00K | $1.50M | $1.00M | $184.41K | $14.00K | $3.12M | – |
| Steven Sell Former Chief Executive Officer and President | $431.51K | $4.05M | $2.25M | – | $546.88K | $7.28M | +34% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
IPO
From the final prospectus (Form 424B4) and the first day of trading
Offering
- Type
- Initial public offering
- Final prospectus filed
- Apr 16, 2021
- Offer price
- $23.00
- Securities offered
- 46,600,000
- Gross proceeds
- $1.07B
- Exchange
- NYSE
- First trading day
- Apr 15, 2021
- First-day close
- $31.00+34.8%
- Lock-up ends (est.)
- Oct 12, 2021
“The initial public offering price per share is $23.00.”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Employees
Headcount reported in annual reports
“As of December 31, 2025, agilon and its subsidiaries had 856 employees; substantially all were full-time.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Nov 7, 2025 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Apr 16, 2021 | IPO | Initial public offering priced (424B4 prospectus) |
| Apr 14, 2021 | Listing | Registration of securities on an exchange (Form 8-A) |
| Feb 10, 2021 | Name change | Name changed from Agilon Health Topco, Inc. to agilon health, inc. |
See a number that looks wrong?